![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. 161596-47-0
2. (s)-n-glycidylphthalimide
3. (s)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione
4. 2-[(2s)-oxiran-2ylmethyl]-1h-isoindole-1,3(2h)-dione
5. 2-[[(2s)-oxiran-2-yl]methyl]isoindole-1,3-dione
6. 1h-isoindole-1,3(2h)-dione, 2-[(2s)-oxiranylmethyl]-
7. 2-[(2s)-2-oxiranylmethyl]-1h-isoindole-1,3(2h)-dione
8. 2-[(2s)-oxiran-2-ylmethyl]-1h-isoindole-1,3(2h)-dione
9. 1h-isoindole-1,3(2h)-dione, 2-[(2s)-2-oxiranylmethyl]-
10. 1h-isoindole-1,3(2h)-dione, 2-((2s)-2-oxiranylmethyl)-
11. Mfcd04973350
12. Unii-9ga7c6l4s5
13. Glycidyl Phthalimide, (s)-
14. Schembl78821
15. N-[(s)-glycidyl]phthalimide
16. 9ga7c6l4s5
17. (s)-( )-glycidyl Phthalimide
18. Dtxsid80352110
19. Zinc119624
20. Cs-m1834
21. N-((s)-(+)-glycidyl)phthalimide
22. (s)-glycidyl Phthalimide [usp-rs]
23. Akos016842501
24. Am84540
25. Gs-3726
26. (s)-2-oxiranylmethylisoindole-1,3-dione
27. Ac-23326
28. N-[(2s)-oxiran-2-ylmethyl]-phthalimide
29. G0328
30. (s)-2-(oxiran-2-ylmethy)isoindoline-1,3-dione
31. 596g470
32. A853175
33. (s)-2-(oxiran-2-yl Methyl)isoindoline-1,3-dione
34. (s)-2-(oxiran-2-ylmethyl) Isoindoline-1,3-dione
35. 2-(((s)-oxiran-2-yl)methyl)isoindoline-1,3-dione
36. Q-102521
37. (s)-2-[2-oxiranylmethyl]-1h-isoindole-1,3(2h)-dione
38. 2-[(2s)-2-oxiranylmethyl]-1h-isoindole-1,3(2h)dione
39. (s)-2-(oxiran-2-ylmethyl)-1h-isoindole-1,3(2h)-dione
40. 2-[(25)-2-oxiranylmethyl]-1h-isoindole-1,3(2h)-dione
41. 2-[(2s)-2-oxiranylmethyl]-1h-isoindole-1,3-(2h)-dione
42. 2-[(2s)-oxiran-2yl Methyl]-1h-isoindole-1,3(2h)dione
43. (s)-(+)-n-(2,3-epoxypropyl)phthalimide, >=99.0% (gc)
44. 2-{[(2s)-oxiran-2-yl]methyl}-1h-isoindole-1,3(2h)-dione
45. 2-{[(2s)-oxiran-2-yl]methyl}-2,3-dihydro-1h-isoindole-1,3-dione
Molecular Weight | 203.19 g/mol |
---|---|
Molecular Formula | C11H9NO3 |
XLogP3 | 1.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 203.058243149 g/mol |
Monoisotopic Mass | 203.058243149 g/mol |
Topological Polar Surface Area | 49.9 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 291 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.